Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study - Vigipallia

0 avis

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Archive ouverte

de Nonneville, Alexandre | Gonçalves, Anthony | Zemmour, Christophe | Classe, Jean | Cohen, Monique | Lambaudie, Eric | Reyal, Fabien | Scherer, Christophe | Muracciole, Xavier | Colombo, Pierre | Giard, Sylvia | Rouzier, Roman | Villet, Richard | Chopin, Nicolas | Darai, Emile | Garbay, Jean | Gimbergues, Pierre | Sabiani, Laura | Coutant, Charles | Sabatier, Renaud | Bertucci, François | Boher, Jean | Houvenaeghel, Gilles

Edité par CCSD ; Springer Verlag -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX

Archive ouverte | de Nonneville, Alexandre | CCSD

International audience

RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

Archive ouverte | Bertucci, François | CCSD

International audience

The MonarchE trial: improving the clinical outcome in HR + /HER2 − early breast cancer: recent results and next steps

Archive ouverte | Bertucci, François | CCSD

International audience

Chargement des enrichissements...